Minerva Neurosciences Inc
NASDAQ:NERV
Minerva Neurosciences Inc
NASDAQ:NERV
Price:
5.26
USD
0.77%
Market Closed
Market Cap:
$227.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Minerva Neurosciences Inc
NASDAQ:NERV
|
US |
|
Q
|
Quest Capital Markets Ltd
BSE:500069
|
IN |
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
UK |
|
Ringkjoebing Landbobank A/S
CSE:RILBA
|
DK |
|
B
|
British American Tobacco PLC
XBER:BMT
|
UK |
|
Connect Biopharma Holdings Ltd
NASDAQ:CNTB
|
CN |
|
Alpha Services and Holdings SA
OTC:ALBKY
|
GR |
Wall St Price Targets
NERV Price Targets Summary
Minerva Neurosciences Inc
Minerva Neurosciences Inc
Wall Street analysts forecast NERV stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for NERV is 9.69 USD with a low forecast of 7.07 USD and a high forecast of 14.7 USD.
Lowest Forecast
Price Target
7.07
USD
34% Upside
Average Forecast
Price Target
9.69
USD
84% Upside
Highest Forecast
Price Target
14.7
USD
179% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NERV's stock price target?
Price Target
9.69
USD
9.69
USD
According to Wall Street analysts, the average 1-year price target for NERV is 9.69 USD with a low forecast of 7.07 USD and a high forecast of 14.7 USD.
What is the Net Income forecast for Minerva Neurosciences Inc?
Projected CAGR
103%
103%
The compound annual growth rate for Net Income over the next 7 years is 103%.
